Patent ID: 11896682
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  C

Claim 0:
1. A radiolabeled antibody conjugate comprising:
(a) an antibody or antigen-binding fragment thereof that binds MET, wherein the antibody or antigen-binding fragment thereof comprises: (i) three heavy chain complementarity determining regions (HCDRs) in a heavy chain variable region (HCVR) having an amino acid sequence selected from the group consisting of SEQ ID NO: 2, 10, 18, 26, 34, 42, 50, 58, 66, 74, 82, 90, 98, 106, 114, 122, and 130; and (ii) three light chain complementarity determining regions (LCDRs) in a light chain variable region (LCVR) having an amino acid sequence of SEQ ID NO: 138,
(b) a chelating moiety, and
(c) a positron emitter.